Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)

PHASE4RecruitingINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

May 27, 2024

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Urinary Incontinence in Children
Interventions
DRUG

Solifenacin

"Abrupt withdrawal indicates stopping the medication on the date of withdrawal initiation.~Gradual withdrawal involves taking the applied dosage of the medication every other day over a period of 14 days, with the complete cessation of the medication occurring 14 days after the gradual withdrawal process begins."

DRUG

Mirabegron

"Abrupt withdrawal indicates stopping the medication on the date of withdrawal initiation.~Gradual withdrawal involves taking the applied dosage of the medication every other day over a period of 14 days, with the complete cessation of the medication occurring 14 days after the gradual withdrawal process begins."

DRUG

Solifenacin + Mirabegron

"Abrupt withdrawal indicates stopping the medication on the date of withdrawal initiation.~Gradual withdrawal involves taking the applied dosage of the medication every other day over a period of 14 days, with the complete cessation of the medication occurring 14 days after the gradual withdrawal process begins."

Trial Locations (5)

6000

NOT_YET_RECRUITING

Department of Pediatric and Adolescent Medicine, Kolding Hospital, Kolding

6700

NOT_YET_RECRUITING

Department of Pediatric and Adolescent medicine, Esbjerg Hospital, Esbjerg

7400

RECRUITING

Department of Pediatric and Adolescent Medicine, Gødstrup Hospital, Herning

8200

RECRUITING

Department of Pediatric and Adolescent Medicine, Aarhus University Hospital, Aarhus

9000

RECRUITING

Department of Pediatric and Adolescent Medicine, Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

University of Aarhus

OTHER